Vimarsana
Biggest News Aggregation in the World

Page 2 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Interval Today - Breaking & Trending Today

Zodasiran Reduces Triglycerides, ANGPTL3 in Mixed Hyperlipidemia in ARCHES-2 Trial - Vimarsana News

Zodasiran Reduces Triglycerides, ANGPTL3 in Mixed Hyperlipidemia in ARCHES-2 Trial

A phase 2 trial suggests zodasiran significantly reduces triglycerides in patients with mixed hyperlipidemia, showing dose-dependent improvements in lipid profiles.

Robert Rosenson, MD: RNAi Therapies Show Promise in Mixed Hyperlipidemia - Vimarsana News

Robert Rosenson, MD: RNAi Therapies Show Promise in Mixed Hyperlipidemia

Robert Rosenson, MD, discusses the unmet need in mixed hyperlipidemia and the potential for RNA interference therapies in this patient population.

High Mediterranean Diet Adherence Tied to Fewer Anxiety, Stress Symptoms - Vimarsana News

High Mediterranean Diet Adherence Tied to Fewer Anxiety, Stress Symptoms

Adherence to a Mediterranean diet is inversely associated with the severity of anxiety and stress symptoms in older adults.

Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease - Vimarsana News

Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.

Topiramate for prenatal antiseizure therapy is not associated autism spectrum disorder - Vimarsana News

Topiramate for prenatal antiseizure therapy is not associated autism spectrum disorder

1. In this retrospective cohort study, exposure to antiseizure medications was associated with a higher incidence of autism spectrum disorder (ASD) compared to general population data. 2. Restricted to children born to mothers with epilepsy, valproate, but not topiramate and lamotrigine, was associated with an increased risk of ASD compared to no medication exposure. Evidence